Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis

Documenti analoghi

• The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
  di: Chun‐Ting Ho, et al.
  Pubblicazione: (2024)
• Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
  di: Ka Shing Cheung, et al.
  Pubblicazione: (2024)
• Gastrointestinal: Eosinophilic peritonitis, an uncommon presentation of eosinophilic gastroenteritis
  di: P Xu, et al.
  Pubblicazione: (2024)
• Safety and efficacy of endoscopic submucosal dissection with gel immersion technique for superficial esophageal neoplasms
  di: Taro Iwatsubo, et al.
  Pubblicazione: (2024)
• Impact of metabolic unhealthiness and its changes on the risk of erosive esophagitis: a cohort study
  di: Nam Hee Kim, et al.
  Pubblicazione: (2024)